Form 8-K - Current report:
SEC Accession No. 0001104659-25-008331
Filing Date
2025-02-03
Accepted
2025-02-03 06:30:47
Documents
15
Period of Report
2025-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm255269d1_8k.htm   iXBRL 8-K 35736
2 EXHIBIT 99.1 tm255269d1_ex99-1.htm EX-99.1 548438
6 GRAPHIC tm255269d1_8kimg01.jpg GRAPHIC 3904
  Complete submission text file 0001104659-25-008331.txt   808172

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20250203.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20250203_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20250203_pre.xml EX-101.PRE 22353
18 EXTRACTED XBRL INSTANCE DOCUMENT tm255269d1_8k_htm.xml XML 3566
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 25580522
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)